Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis
Mina Homayoonfal, Zatollah Asemi, Bahman Yousefi
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Plants as a Source of Anticancer Agents: From Bench to Bedside
Wamidh H. Talib, Safa Daoud, Asma Ismail Mahmod, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4818-4818
Open Access | Times Cited: 46
Melatonin and cancer suppression: insights into its effects on DNA methylation
Amirhossein Davoodvandi, Banafsheh Nikfar, Russel J. Reıter, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 38
5-Fluorouracil in Combination with Calcium Carbonate Nanoparticles Loaded with Antioxidant Thymoquinone against Colon Cancer: Synergistically Therapeutic Potential and Underlying Molecular Mechanism
Xi Deng, Zhongming Yang, Kim Wei Chan, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1030-1030
Open Access | Times Cited: 7
Potential anticancer properties and mechanisms of thymoquinone in colorectal cancer
Farhad Sheikhnia, Vahid Rashidi, Hossein Maghsoudi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Characterization of Thymoquinone-Sulfobutylether-β-Cyclodextrin Inclusion Complex for Anticancer Applications
Eltayeb E. M. Eid, Amer A. Almaiman, Salah Abdalrazak Alshehade, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4096-4096
Open Access | Times Cited: 13
Investigating Anti-Cancer Activity of Dual-Loaded Liposomes with Thymoquinone and Vitamin C
Ahmed Munef, Zainab Lafi, Naeem Shalan
Therapeutic Delivery (2024) Vol. 15, Iss. 4, pp. 267-278
Closed Access | Times Cited: 5
Biological and Clinical Aspects of Metastatic Spinal Tumors
Jakub Litak, Wojciech Czyżewski, Michał Szymoniuk, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4599-4599
Open Access | Times Cited: 19
Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling
Yibin Lin, Xiaohong Chen, Linping Lin, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4
Promotion of Autophagy and Apoptosis in Colorectal Cancer Exposed to Imatinib and Thymoquinone
Dalia El‐Khouly, Nadia A. Thabet, Mohamed M. Sayed‐Ahmed, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 4
Open Access
UPLC-QE-Orbitrap-Based Cell Metabolomics and Network Pharmacology to Reveal the Mechanism of N-Benzylhexadecanamide Isolated from Maca (Lepidium meyenii Walp.) against Testicular Dysfunction
Kaiyue Zhang, Chunnan Li, Nan-Xi Zhang, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4064-4064
Open Access | Times Cited: 10
Monoterpenoids: An upcoming class of therapeutic agents for modulating cancer metastasis
Anurag Mathur, Abha Meena, Suaib Luqman
Phytotherapy Research (2023) Vol. 38, Iss. 2, pp. 939-969
Closed Access | Times Cited: 9
Thymoquinone protects thioacetamide‐induced chronic liver injury by inhibiting TGF‐β1/Smad3 axis in rats
Raghunandhakumar Subramanian, Devaraj Ezhilarasan, Karthik Shree Harini
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 4
Closed Access | Times Cited: 3
SIX4 upregulates IDH1 and metabolic reprogramming to promote osteosarcoma progression
Bing Li, Xiaoqian Dang, Jiafeng Duan, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 2, pp. 259-265
Open Access | Times Cited: 7
An efficient methodological approach for synthesis of selenopyridines: generation, reactions, anticancer activity, EGFR inhibitory activity and molecular docking studies
Bahgat R. M. Hussein, Sham M. M. El-Saghier, Rasha M. Allam, et al.
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 519-534
Open Access | Times Cited: 2
Analytical Approaches for Assessing Curcumin and Nicotinamide Co-Encapsulated in Liposomal Formulation: UV Spectrophotometry and HPLC Validation
Ali Fahdawi, Naeem Shalan, Zainab Lafi, et al.
Jordan Journal of Pharmaceutical Sciences (2024) Vol. 17, Iss. 3, pp. 468-480
Closed Access | Times Cited: 2
Anticancer Effect of Spices Used in Mediterranean Diet: Preventive and Therapeutic Potentials
Wamidh H. Talib, Mallak J. AlHur, Sumaiah Al.Naimat, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 10
Enhancing the Anti-Leukemic Potential of Thymoquinone/Sulfobutylether-β-cyclodextrin (SBE-β-CD) Inclusion Complexes
Eltayeb E. M. Eid, Salah Abdalrazak Alshehade, Amer A. Almaiman, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1891-1891
Open Access | Times Cited: 6
The Targeted Therapies for Osteosarcoma via Six Major Pathways
Shuxing Wang, Quanlei Ren, Guoqing Li, et al.
Current Molecular Pharmacology (2023) Vol. 17
Open Access | Times Cited: 6
Meso‐Hannokinol inhibits breast cancer bone metastasis via the ROS/JNK/ZEB1 axis
Yuan Zhu, Weifeng Yin, Pei Yu, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 6, pp. 2262-2279
Closed Access | Times Cited: 5
Co-delivery of exemestane and thymoquinone via nanostructured lipid carriers for efficient breast cancer therapy
Priya Gupta, Shwetakshi Sharma, Yub Raj Neupane, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 88, pp. 104892-104892
Closed Access | Times Cited: 5
Thymoquinone-protoflavone hybrid molecules as potential antitumor agents
Sara Hassan Hassan Ahmed, Bizhar Ahmed Tayeb, Tímea Gonda, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0291567-e0291567
Open Access | Times Cited: 1
Tumoricidal properties of thymoquinone on human colorectal adenocarcinoma cells via the modulation of autophagy
Mohammad Saleh Moulana, Sanya Haiaty, Ahad Bazmani, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Amicis Omnia Sunt Communia: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity
Mariana Medeiros, Sophia Guenka, David Bastos, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 734-734
Open Access | Times Cited: 1
Nano-based formulations of thymoquinone are new approaches for psoriasis treatment: a literature review
Amir Modarresi Chahardehi, Hamid Reza Ojaghi, Hossein Motedayyen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Targeting Cancer Hallmarks Using Selected Food Bioactive Compounds: Potentials for Preventive and Therapeutic Strategies
Wamidh H. Talib, Ilia Abed, Daniah Raad, et al.
Foods (2024) Vol. 13, Iss. 17, pp. 2687-2687
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top